SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (8924)3/4/1999 7:31:00 AM
From: opalapril  Read Replies (1) | Respond to of 17367
 
Thanks, but here's what I think is an important part of the FAQ you left out --

If XOMA does not have a corporate partner for NEUPREX® before you get
approval for the meningococcemia indication, would you pursue marketing? (2/99)

Given what we know so far about the potential market we would probably sell it ourselves or with a small partner as a niche indication.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News